Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Candesartan

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 720Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IOL Chemicals secures patent for invention related to preparation of Sartan drugs
    IOL Chemicals secures patent for invention related to preparation of Sartan drugs

    27 Nov 2022

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/news-cm/iol-chemicals-secures-patent-for-invention-related-to-preparation-of-sartan-drugs-122112400926_1.html

    BUSINESS-STANDARD
    27 Nov 2022
    Share Share
    China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests
    China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests

    05 Aug 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/china-pharmas-candesartan-hypertension-product-passes-bioequivalence-tests-and-the-company-plans-to-apply-for-nmpa-approval-301348981.html

    PRNEWSWIRE
    05 Aug 2021
    Share Share
    Candesartan Is Associated With Lower Amyloid Accumulation
    Candesartan Is Associated With Lower Amyloid Accumulation

    26 Jul 2021

    // FIRSTWORDPHARMA

    https://www.firstwordpharma.com/node/1849161?tsid=4

    FIRSTWORDPHARMA
    26 Jul 2021
    Share Share
    Candesartan Is Associated With Lower Amyloid Accumulation
    Candesartan Is Associated With Lower Amyloid Accumulation

    26 Jul 2021

    // FIRSTWORDPHARMA

    https://www.firstwordpharma.com/node/1849161?tsid=4

    FIRSTWORDPHARMA
    26 Jul 2021
    Share Share
    TGA investigation - potential contamination with N-nitroso compounds
    TGA investigation - potential contamination with N-nitroso compounds

    26 Feb 2019

    // TGA

    https://www.tga.gov.au/alert/sartan-blood-pressure-medicines

    TGA
    26 Feb 2019
    Share Share
    Update on the EDQM review of CEP applications for sartan substances (4 Feb 2019)
    Update on the EDQM review of CEP applications for sartan substances (4 Feb 2019)

    04 Feb 2019

    // EDQM

    https://www.edqm.eu/en/news/update-edqm-review-cep-applications-sartan-substances-4-february-2019

    EDQM
    04 Feb 2019
    Share Share